Botulinum Type A: Key Clinical Postulates
October 23rd 2021Botulinum type A injections are widely used across the dermatology and aesthetic medicine specialties. At the Fall Clinical Dermatology Conference 2021, Mark S Nestor, MD, PhD, highlights how to optimize the neurotoxin to improve patient care.
Step Up Skin Microbiome Understanding to Advance AD Treatment
October 23rd 2021People are born with sterile skin and then gain microbiota throughout their life. Lawrence J. Green, MD, FAAD, explains how this affects the skin barrier and ultimately plays a role in atopic dermatitis at the 2021 Fall Clinical Dermatology Conference.
Genetic expression profiling for squamous cell carcinoma
October 18th 2019For many years, genetic expression profiling has helped physicians predict which patients are at the highest risk of having their melanoma metastasize. Now, this same approach could aid in treating squamous cell carcinoma of the skin.
Treatment options for benign lesions
October 19th 2018Patients are increasingly seeking to have benign lesions removed and today, there are a number of treatment options available to safely and effectively remove unwanted lesions. Suneel Chilukuri, M.D., reviewed these options during a presentation at the Fall Clinical Dermatology Conference held this week in Las Vegas.
More new therapies under study for underarm sweat
October 19th 2018Qbrexza was approved earlier this year for primary axillary hyperhidrosis. And, now, other treatments are under study. In his presentation at this week’s Fall Clinical Dermatology Conference in Las Vegas, Dr. David Pariser summarizes the latest research.